Intron 4 polymorphism of the endothelial nitric oxide synthase eNOS gene and early microangiopathy in type 1 diabetes

International Journal of Immunogenetics

Volumn 36, Issue 3, 2009, Pages 153-157

  Mamoulakis, D ^b   Bitsori, M ^b   Galanakis, E ^b   Vazgiourakis, V ^c   Panierakis, C ^b   Goulielmos, G N ^a,c  

^a Department of Medicine Voutes ^*  (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^c UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; FEMALE; FOLLOW UP; GENE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOPATHY; SCHOOL CHILD; VARIABLE NUMBER OF TANDEM REPEAT; WILD TYPE;

ADOLESCENT; ADULT; ALLELES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENOTYPE; HUMANS; INTRONS; MALE; NITRIC OXIDE SYNTHASE TYPE III; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 65649112442     PISSN: 17443121     EISSN: 1744313X     Source Type: Journal    
DOI: 10.1111/j.1744-313X.2009.00839.x     Document Type: Article

References (39)

1. Beckman, J.S. Koppenol, W.H. (1996) Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. American Journal of Physiology, 271, C1424. (Pubitemid 26404872)
2. Beckman, J.S., Beckman, T.W., Chen, J., Marchall, P. Freeman, B. (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proceedings of the National Academy of Sciences USA, 87, 1620. (Pubitemid 20080360)
3. Bellini, M.H., Figueira, M.N., Piccoli, M.F., Marumo, J.T., Cendoroglo, M.S., Neto, M.C. et al 2007) Association of endothelial nitric oxide synthase gene intron 4 polymorphism with end-stage renal disease. Nephrology, 12, 289. (Pubitemid 46718205)
4. Buraczynska, M., Ksiazek, P., Zaluska, W., Nowicka, T. Ksiazek, A. (2004) Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease. Nephrology Dialysis Transplantation, 9, 2302. (Pubitemid 39214125)
5. Calver, A., Collier, J. Vallance, P. (1992) Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. Journal of Clinical Investigation, 90, 2548. (Pubitemid 23010077)
6. Campbell, F.M. (1995) Microalbuminuria and nephropathy in insulin dependent diabetes mellitus. Archives of Disease in Childhood, 73, 4.
7. Celermajer, D.S. (1997) Endothelial function: does it matter? Is it reversible? Journal of the American College of Cardiology, 30, 325. (Pubitemid 27339309)
8. Chan, N.N., Vallance, P., Colhoun, H.M. (2000) Nitric oxide and vascular responses in type I diabetes. Diabetologia, 43, 137. (Pubitemid 30126817)
9. Colasanti, M. Suzuki, H. (2000) The dual personality of NO. Trends in Pharmacological Sciences, 21, 49. (Pubitemid 30445251)
10. Cooke, J.P. Dzau, V.J. (1997) Nitric oxide synthase: role in the genesis of vascular disease. Annual Review of Medicine, 48, 489. (Pubitemid 27101848)
11. De Clue, T.J. Campers, A. (1994) Diabetic nephropathy in a prebubertal diabetic female. Pediatric Endocrinology, 7, 43.
12. Ding, Y., Vaziri, N.D., Coulson, R., Kamanna, V.S. Roh, D.D. (2000) Effect of simulated hyperglycemia, insulin, and glucagons on endothelial nitric oxide synthase expression. American Journal of Physiology. Endocrinology and Metabolism, 279, E11. (Pubitemid 30609939)
13. EURODIAB ACE Study Group (2000) Variation and trends in incidence of childhood diabetes in Europe. Lancet, 355, 873.
14. Francis, J., Rose, S.J., Raafat, F. Milford, D. 1997) Early onset diabetic nephropathy. Archives of Disease in Childhood, 77, 524. (Pubitemid 28016375)
15. Galanakis, E., Kofteridis, D., Stratigi, K., Petraki, E., Vazgiourakis, V., Fragouli, E., Mamoulakis, D., Boumpas, D.T. Goulielmos, G.N. (2008) Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population. Human Immunology, 69, 279.
16. Gryglewski, R.J., Palmer, R.M. Moncada, S. (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature, 320, 454. (Pubitemid 16097810)
17. Hibi, K., Ishigami, T., Tamura, K., Mizushima, S., Nyui, N., Fujita, T. et al 1998) Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension, 32, 521. (Pubitemid 28429143)
18. Koo, J.-R. Vasiri, N.D. (2003) Effects of diabetes, insulin and antioxidants on NO synthase abundance and NO interaction with reactive oxygen species. Kidney International, 63, 195. (Pubitemid 35463921)
19. Lamnissou, Ê., Zirogiannis, P., Trygonis, S., Demetriou, K., Pierides, A., Koptides, M. Deltas, C.C. (2004) Evidence for association of endothelial cell nitric oxide synthase gene polymorphism with earlier progression to end-stage renal disease in a cohort of Hellens from Greece and Cyprus. Genetic Testing, 8, 319. (Pubitemid 39586803)
20. Li, H. Forstermann, U. (2000) Nitric oxide in the pathogenesis of vascular disease. The Journal of Pathology, 190, 244. (Pubitemid 30141371)
21. Mamoulakis, D., Galanakis, E., Bicouvarakis, S., Paraskakis, E. Sbyrakis, S. (2003) Epidemiology of childhood type I diabetes in Crete 1990-2001. Acta Paediatrica, 92, 737. (Pubitemid 37088686)
22. Marsden, P.A., Heng, H.H., Scherer, S.W., Stewart, R.J., Hall, A.V., Shi, X.M., Tsui, L.C. Schappert, K.T. (1993) Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. The Journal of Biological Chemistry, 268, 17478. (Pubitemid 23236991)
23. Miyahara, K., Kawamoto, T., Sase, K., Yui, Y., Toda, K., Yang, L.X. et al 1994) Cloning and structural characterization of the human endothelial nitric oxide synthase gene. European Journal of Biochemistry, 223, 719. (Pubitemid 24263152)
24. Nagase, S., Suzuki, H., Wang, Y., Kikuchi, S., Hirayama, A., Ueda, A. et al 2003) Association of ecNOS gene polymorphisms with end stage renal diseases. Molecular and Cellular Biochemistry, 244, 113. (Pubitemid 36411061)
25. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents 2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics, 114 (2 Suppl 4th Report 555.
26. Neugebauer, S., Baba, T. Watanabe, T. (2000) Association of the nitric oxide synthase gene polymorphism with an increased risk for progression to diabetic nephropathy in type 2 diabetes. Diabetes, 49, 500. (Pubitemid 30131798)
27. Noiri, E., Satoh, H., Taguchi, J., Brodsky, S.V., Nakao, A., Ogawa, Y., Nishijima, S., Yokomizo, T., Tokunaga, K. Fujita, T. (2002) Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension, 40, 535.
28. Onkamo, P., Vaananen, S., Karvonen, M. Tuomilehto, J. (1999) Worldwide increase in incidence of type 1 diabetes-the analysis of the data on published incidence trends. Diabetologia, 42, 1395. (Pubitemid 30012309)
29. Peltonen, L., Jalanko, A. Varilo, T. (1999) Molecular genetics of the Finnish disease heritage. Human Molecular Genetics, 8, 1913. (Pubitemid 29458670)
30. Shin, Y., Baek, S.H., Chang, K.Y., Park, C.W., Yang, C.W., Jin, D.C., Kim, Y.S., Chang, Y.S. Bang, B.K. (2004) Relations between eNOS Glu298Asp polymorphism and progression of diabetic nephropathy. Diabetes Research and Clinical Practice, 65, 257. (Pubitemid 39141182)
31. Suganthalakshmi, B., Anand, R., Kim, R., Mahalakshmi, R., Karthikprakash, S., Namperumalsamy, P. Sundaresan, P. (2006) Association of VEGF and eNOS gene polymorphisms in type 2 diabetic retinopathy. Molecular Vision, 11, 336.
32. Svensson, M., Sundkvist, G., Arnqvist, H.J., Bjork, E., Blohme, G., Bolinder, J. et al 2004) Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management. Diabetes Care, 26, 2903.
33. Taverna, M.J., Elgrably, F., Selmi, H., Selam, J.-L. Slama, G. (2005) The T-786C and C774T endothelial nitric oxide synthase gene polymorphisms independently affect the onset pattern of severe diabetic retinopathy. Nitric Oxide, 13, 88. (Pubitemid 40853973)
34. Trachtman, H., Futterweit, S., Pine, E., Mann, J. Valderrama, E. (2002) Chronic diabetic nephropathy: role of inducible nitric oxide synthase. Pediatric Nephrology, 17, 20. (Pubitemid 41490200)
35. Tsukada, T., Yokoyama, K., Arai, T., Takemoto, F., Hara, S., Yamada, A., Kawaguchi, Y., Hosoya, T. Igari, J.Y. (1998) Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochemical and Biophysical Research Communications, 245, 190. (Pubitemid 28414268)
36. Wang, X.L. Wang, J. (2000) Endothelial nitric oxide synthase gene sequence variations and vascular disease. Molecular Genetics and Metabolism, 70, 241.
37. Wang, J., Dudley, D. Wang, X.L. (2002) Haplotype-specific effects on endothelial NO synthase promoter efficiency: modifiable by cigarette smoking. Arteriosclerosis, Thrombosis and Vascular Biology, 22, 1.
38. West, I.C. (2000) Radicals and oxidative stress in diabetes. Diabetic Medicine, 17, 171. (Pubitemid 30212288)
39. Zanchi, A., Moczulski, D.K., Hanna, L.S., Wantman, M., Warram, J.H. Krolewski, A.S. (2000) Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney International, 57, 405. (Pubitemid 30430632)